Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.
D000933:Antifibrinolytic Agents; D003374:Coumarins / Q000031:analogs & derivatives; D005017:Ethyl Biscoumacetate; D006494:Heparin Antagonists; D009285:Naphthoquinones; D010630:Phenindione / Q000627:therapeutic use*; D013923:Thromboembolism / Q000628:therapy*; D014812:Vitamin K / Q000494:pharmacology*; D010837:Vitamin K 1
D000933:Antifibrinolytic Agents; D003374:Coumarins; D006494:Heparin Antagonists; D009285:Naphthoquinones; D005017:Ethyl Biscoumacetate; D014812:Vitamin K; D010630:Phenindione; D010837:Vitamin K 1; C030123:coumarin
COUMARIN/derivatives; PHENINDIONE/therapeutic use; THROMBOEMBOLISM/therapy; VITAMIN K/effects